- Home
- TCRT vs DUKRW Comparison
TCRT vs DUKRW Comparison
Compare TCRT & DUKRW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$2.10
N/A
Current Price
$1.11
Company Overview
Basic Information| Metric | TCRT | DUKRW |
|---|---|---|
| Founded | 1998 | N/A |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Aerospace |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.3M | 4.3M |
| IPO Year | 2025 | N/A |
Fundamental Metrics
Financial Performance| Metric | TCRT | DUKRW |
|---|---|---|
| Price | $2.10 | $1.11 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 12.5K | 11.7K |
| Earning Date | 05-14-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 24.66 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $15,900,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.67 | $0.70 |
| 52 Week High | $4.57 | $1.43 |
Technical Indicators
Market Signals| Indicator | TCRT | DUKRW |
|---|---|---|
| Relative Strength Index (RSI) | 44.02 | 31.50 |
| Support Level | $1.92 | $1.01 |
| Resistance Level | $2.43 | $1.29 |
| Average True Range (ATR) | 0.14 | 0.13 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 24.00 | 54.84 |
Price Performance
Historical Comparison TCRT
DUKRW
About TCRT Alaunos Therapeutics Inc.
Alaunos Therapeutics Inc is a preclinical-stage biopharmaceutical company focused on the development of novel, orally administered small-molecule therapeutics for obesity and related metabolic disorders, such as metabolic dysfunction-associated steatotic liver disease (MASLD, a type of fatty liver disease). The program aims to develop a differentiated, non-hormonal, non-incretin approach, unlike hormone-based treatments like GLP-1 drugs. It has a single reportable and operating segment related to biopharmaceutical research and development.